Overview
What it is.
Survodutide is a dual GLP-1/glucagon receptor agonist studied in formal research programs for effects on liver fat content alongside the appetite- and weight-related outcomes typical of incretin-pathway research.
Research Areas
- Studied in formal research programs for its dual GLP-1/glucagon mechanism
- Studied for its potential role in liver-fat-related research outcomes
- Studied for its potential role in body-composition research
Batch & Testing
Proof, not promises.
COA ships with every order
The Certificate of Analysis for your batch ships in the box with your order. We're publishing the certificate archive here next.
Research Deep-Dive
How it works.
Research Deep-Dive
How it works.
Survodutide is a dual GLP-1/glucagon receptor agonist studied in formal clinical research programs, with a particular research emphasis on liver-fat content in addition to the appetite- and weight-related outcomes typical of incretin-pathway compounds.
Combining GLP-1-receptor activity with glucagon-receptor activity is studied for effects that extend beyond appetite suppression into hepatic fat metabolism, an angle that has drawn particular research interest for this compound relative to single-pathway GLP-1 agonists.
Use Cases Explored
- Studied in formal research programs for its dual GLP-1/glucagon mechanism
- Studied for its potential role in liver-fat-related research outcomes
- Studied for body-composition research
The Evidence
Phase 2 clinical trials
Survodutide has been examined in Phase 2 clinical trial programs for body-weight and liver-fat-related outcomes in defined study populations; broad Phase 3 data was not publicly available at the time this catalog was compiled.
Comparative dual-agonist research
Its mechanism is often discussed alongside other GLP-1/glucagon and GLP-1/GIP dual agonists, though independent replication outside sponsor-affiliated trials is limited.
Specifications
The essentials.
Specifications
The essentials.
- Form
- Lyophilized powder
- Storage
- Store in a cool, dry place. Refrigerate at 2–8°C after reconstitution
- Shelf life
- 24 months lyophilized; 4–6 weeks refrigerated after reconstitution
- Solubility
- Reconstitute with bacteriostatic water
- Vial capacity
- 3 ml glass vial
Questions
Survodutide FAQ
Questions
Survodutide FAQ
What is Survodutide studied for?+
Survodutide is studied as a dual GLP-1/glucagon receptor agonist, examined in formal research programs for effects on liver-fat content alongside the appetite- and weight-related outcomes typical of incretin-pathway research.
What makes Survodutide's research focus on liver fat distinctive?+
Its glucagon-receptor activity is studied specifically for downstream effects on liver-fat content, a research angle less emphasized in single-pathway GLP-1 compounds like Semaglutide.
How should Survodutide be handled and stored?+
It ships as a lyophilized powder in a single 10 mg size. Reconstitute with bacteriostatic water and refrigerate at 2–8°C after mixing — good for roughly 4–6 weeks refrigerated, or up to 24 months unreconstituted in a cool, dry place.
What testing does this batch undergo?+
Every batch is HPLC tested for purity and identity, plus sterility and endotoxin screening, before release. The Certificate of Analysis for that lot ships with your order.
Metabolic
Survodutide
GLP-1/glucagon dual agonist
A dual GLP-1/glucagon receptor agonist studied in liver-fat and metabolic research.
Size
Ships within 24 hours · $20 flat shipping · Free over $200
Pay simply and securely via Zelle or Apple Pay (Apple Cash) — instructions are emailed the moment you order. How payment works →
Satisfaction guarantee — if a batch's documentation doesn't check out, contact support and we'll make it right.
All products sold by One Tap Peptides are intended for laboratory research use only. Not for human consumption. Not intended for animal use. Not intended for diagnostic or therapeutic purposes.
Related
